Invited Commentary: Assessing Gastric and Gastroesophageal Junction Cancer Patient Prognosis in the Neoadjuvant Therapy Era

J Am Coll Surg. 2022 Aug 1;235(2):304-305. doi: 10.1097/XCS.0000000000000216. Epub 2022 May 6.
No abstract available

Publication types

  • Comment

MeSH terms

  • Esophageal Neoplasms* / therapy
  • Esophagogastric Junction
  • Humans
  • Neoadjuvant Therapy
  • Neoplasms*
  • Prognosis
  • Stomach Neoplasms* / surgery